Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 3Head and Neck Neoplasms 3Urinary Bladder Neoplasms 2Tobacco Use Disorder 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2Mouth Neoplasms 2Lung Neoplasms 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Laryngeal Neoplasms 2Kidney Neoplasms 2Hypopharyngeal Neoplasms 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Breast Neoplasms 2cyclopia sequence 1Vulvar Neoplasms 1Vaginal Neoplasms 1Overweight 1Ovarian Neoplasms 1Obesity 1Melanoma 1Laryngeal Diseases 1

Interventions

Cisplatin 3fludarabine phosphate 2fludarabine 2aldesleukin 2Radiation 2Platinum 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Cyclophosphamide 2Congresses as Topic 2Brachytherapy 23-aminopyridine-2-carboxaldehyde thiosemicarbazone 21,2-diaminocyclohexaneplatinum II citrate 2rocakinogene sifuplasmid 1durvalumab 1alovudine 1adavosertib 1Vaccines, Synthetic 1VGX-3100 1Sonazoid 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiosurgery 1Magnetic Resonance Spectroscopy 1MEDI0457 1Interleukin-2 1Immunoglobulin G 1Fondaparinux 1Fluorodeoxyglucose F18 1Fentanyl 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Vaginal Neoplasms × Bupropion × Clear all
NCT03180294 2026-05-19

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

NRG Oncology

Phase 2 Completed
230 enrolled 24 charts
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡